Selection of new TP53 mutations by therapy in chronic lymphocytic leukemia

Leuk Res. 2011 Jul;35(7):981-2. doi: 10.1016/j.leukres.2011.02.005. Epub 2011 Mar 3.

Authors

Martin Trbusek¹, Jitka Malcikova, Jiri Mayer

Affiliation

¹ Department of Internal Medicine, Hematooncology, University Hospital, Masaryk University, Jihlavska 20, 625 00 Brno, Czech Republic. [email protected]

PMID: 21376395
DOI: 10.1016/j.leukres.2011.02.005

No abstract available

Publication types

Comment
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
Mutation / genetics*
Prognosis
Remission Induction
Tumor Suppressor Protein p53 / genetics*

Substances

TP53 protein, human
Tumor Suppressor Protein p53